Northwest Biotherapeutics Inc. (NBYB)
Market Open
12 Jun, 13:32
XSTU 
OTC PINK Primary XSTU €
0. 16
-0.02
-10.5556%
€
289.23M Market Cap
- P/E Ratio
- Div Yield
2,500 Volume
0 Eps
€ 0.18
Previous Close Want to track NBYB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Northwest Biotherapeutics Inc. (NBYB) Statistics
Valuation metrics
Market Cap 289.23M
Enterprise value 309.2M
Trailing P/E (ttm) -4.5
Forward P/E -
PEG ratio -
Price/Sales (ttm) 209.89
Price/Book (mrq) -
Enterprise Value/Revenue 263.96
Enterprise Value/EBITDA -6.29
Overview
Shares outstanding 1.56B
Float 1.57B
Shares short -
% Held by insiders 0.04%
% Held by institutions 0%
Average volume (10 days) 12.54K
Average volume (90 days) 13.43K
Price summary
52-Week low 0.11
52-Week high 0.38
Beta -0.77
50-Day moving average 0.18
200-Day moving average 0.21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 26 Sep 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -20.1%
Operational effectiveness
Return on assets -0.69%
Return on equity 1.02%
Income Statement
Revenue (ttm) 1.17M
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) 1.91%
Gross profit (ttm) -23.3M
EBITDA -49.18M
Net income to common (ttm) -52.26M
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) 1.91%
Balance Sheet
Total cash (mrq) 2.58M
Total cash per share (mrq) 0
Total debt (mrq) 55.11M
Total Debt/Equity (mrq) -0.91
Current ratio (mrq) 0.06%
Book value per share (mrq) -0.03
Cash Flow
Cash flow statement -38.05M
Levered free cash flow (LFCF) -20.36M
